mortality/aging
• midian survival was 6 months
• none survived past 8 months
|
cardiovascular system
• pulmonary congestion
|
• focal appearance of enlarged cardiac myocytes with apparent vacuoles
• scattered intramural foci of enlarged cells with excess glycogen revealed by histologic studies at 2 and 5 month of age
• there was no evidence of proliferative cardiac tumors
|
• with heart enlargement and pulmonary congestion
• a significant increase in LV end-diastolic diameter and LV end-systolic diameter, and a reduction in fractional shortening in 2- to 3-month-old mutant mice by echocardiographic analysis
• increase in heart weight, heart/body weight ratio and heart weight/tibial length ratio
|
• a significant increase in LV end-diastolic diameter and LV end-systolic diameter, and a reduction in fractional shortening in 2- to 3-month-old mutant mice by echocardiographic analysis
|
muscle
• focal appearance of enlarged cardiac myocytes with apparent vacuoles
• scattered intramural foci of enlarged cells with excess glycogen revealed by histologic studies at 2 and 5 month of age
• there was no evidence of proliferative cardiac tumors
|
• with heart enlargement and pulmonary congestion
• a significant increase in LV end-diastolic diameter and LV end-systolic diameter, and a reduction in fractional shortening in 2- to 3-month-old mutant mice by echocardiographic analysis
• increase in heart weight, heart/body weight ratio and heart weight/tibial length ratio
|
• a significant increase in LV end-diastolic diameter and LV end-systolic diameter, and a reduction in fractional shortening in 2- to 3-month-old mutant mice by echocardiographic analysis
|
homeostasis/metabolism
• the presence of thrombus in the left atrium in some
|
respiratory system
• pulmonary congestion
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
tuberous sclerosis | DOID:13515 |
OMIM:PS191100 |
J:96138 |